Prostaglandin-modulated umbilical cord blood hematopoietic stem cells
Ontology highlight
ABSTRACT: Umbilical cord blood (UCB) is a valuable source of hematopoietic stem cells (HSCs) for use in allogeneic transplantation. Key advantages of UCB are rapid availability and less stringent requirements for HLA matching. However, UCB contains an inherently limited HSC count, which is associated with delayed time to engraftment, high graft failure rates and early mortality. 16,16 dimethyl prostaglandin E2 (dmPGE2) was previously identified to be a critical regulator of HSC homeostasis and we hypothesized that a brief ex vivo modulation could improve patient outcomes by increasing the “effective dose” of HSCs. Molecular profiling with Affymetrix GeneChips were used to determine the optimal ex vivo modulation conditions (e.g., temperature and media) for use in a clinical setting by measured pathway induced expression changes.
ORGANISM(S): Homo sapiens
PROVIDER: GSE46569 | GEO | 2013/09/12
SECONDARY ACCESSION(S): PRJNA201017
REPOSITORIES: GEO
ACCESS DATA